Home › RESONANCE HEALTH ANALYSIS SERVICES PTY LTD › T1CMR Phantom (3.0T)

T1CMR Phantom (3.0T)

RESONANCE HEALTH ANALYSIS SERVICES PTY LTD · Model v1.0 · UDI-DI 09355529000064

IXG Prescription

510(k) clearances

Adverse events

Recalls

Facilities

Description

The T1CMR Phantom contains a range of nickel chloride in agarose solutions that mimic cardiac T1 and T2 values. T1 measurement is used to calculate the extravascular volume fraction (ECV) to detect diffuse myocardial fibrosis. It is provided to MRI Centres for the verification of T1-mapping stability across different 3.0T scanners (different manufacturers and models) and to understand the feasibility of delivering a “T1 standard”.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API key Read the docs

Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.